These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 24246415

  • 1. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y, Ishida H, Shimizu T, Tanabe K.
    Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
    [Abstract] [Full Text] [Related]

  • 2. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Jan; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 3. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N.
    Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
    [Abstract] [Full Text] [Related]

  • 4. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 5. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [Abstract] [Full Text] [Related]

  • 6. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [Abstract] [Full Text] [Related]

  • 7. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T, Ishida H, Yamaguchi Y, Tanabe K.
    Transplantation; 2009 Oct 15; 88(7):935-41. PubMed ID: 19935466
    [Abstract] [Full Text] [Related]

  • 8. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N, Yamamoto H, Kobayashi A, Yamamoto I, Mitome J, Maruyama Y, Hayakawa H, Miyazaki Y, Utsunomiya Y, Hosoya T, Yamaguchi Y.
    Clin Transplant; 2009 Aug 15; 23 Suppl 20():23-6. PubMed ID: 19594591
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation.
    Ushigome H, Suzuki T, Fujiki M, Nobori S, Sakamoto S, Okamoto M, Urasaki K, Yoshimura N.
    Clin Transplant; 2009 Aug 15; 23 Suppl 20():17-22. PubMed ID: 19594590
    [Abstract] [Full Text] [Related]

  • 10. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
    Ohya M, Otani H, Minami Y, Yamanaka S, Mima T, Negi S, Yukawa S, Shigematsu T.
    Clin Nephrol; 2013 Jul 15; 80(1):47-52. PubMed ID: 23557791
    [Abstract] [Full Text] [Related]

  • 11. Tonsillectomy ameliorates histological damage of recurrent immunoglobulin A nephropathy after kidney transplantation.
    Hotta K, Fukasawa Y, Akimoto M, Tanabe T, Sasaki H, Fukuzawa N, Seki T, Togashi M, Harada H.
    Nephrology (Carlton); 2013 Dec 15; 18(12):808-12. PubMed ID: 23941658
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K, Takeda K, Nakai K, Takahashi N, Adachi T, Fukuda T, Miura S.
    Nihon Jinzo Gakkai Shi; 2008 Dec 15; 50(8):1017-23. PubMed ID: 19172803
    [Abstract] [Full Text] [Related]

  • 13. Early recurrence of active IgA nephropathy after kidney transplantation.
    Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, Morozumi K.
    Nephrology (Carlton); 2014 Jun 15; 19 Suppl 3():45-8. PubMed ID: 24842823
    [Abstract] [Full Text] [Related]

  • 14. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    Lionaki S, Makropoulos I, Panagiotellis K, Vlachopanos G, Gavalas I, Marinaki S, Liapis G, Michelakis I, Bokos I, Boletis I.
    PLoS One; 2021 Jun 15; 16(8):e0253337. PubMed ID: 34403416
    [Abstract] [Full Text] [Related]

  • 15. [Clinical efficacy of tonsillectomy in renal transplant patients with recurrent IgA nephropathy].
    Zhu L, Feng H, Jia JD, Peng S, Li YQ, Shao JF, He XF, Guan Y, Guo H, Lin ZB, Chen G.
    Zhonghua Yi Xue Za Zhi; 2018 Jan 16; 98(3):176-180. PubMed ID: 29374910
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation.
    Yaginuma T, Yamamoto H, Mitome J, Kobayashi A, Yamamoto I, Tanno Y, Hayakawa H, Miyazaki Y, Yokoyama K, Utsunomiya Y, Miki J, Yamada H, Furuta N, Yamaguchi Y, Hosoya T.
    Clin Transplant; 2011 Jul 16; 25 Suppl 23():28-33. PubMed ID: 21623911
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation.
    Katsumata H, Yamamoto I, Komatsuzaki Y, Kawabe M, Okabayashi Y, Yamakawa T, Katsuma A, Nakada Y, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.
    BMC Nephrol; 2018 Mar 14; 19(1):64. PubMed ID: 29540152
    [Abstract] [Full Text] [Related]

  • 18. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M, Yücetin L, Tekin S, Demirbas A.
    Transplant Proc; 2012 Mar 14; 44(6):1703-5. PubMed ID: 22841248
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T.
    Contrib Nephrol; 2009 Mar 14; 162():61-74. PubMed ID: 19001814
    [Abstract] [Full Text] [Related]

  • 20. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC, Messina M, Fop F, Barreca A, Segoloni GP, Biancone L.
    Clin Transplant; 2018 Apr 14; 32(4):e13207. PubMed ID: 29345747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.